Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
Submitted by
admin
on March 16, 2017 - 10:02am
Source:
RAPS.org
News Tags:
FDA
Allergan
Viberzi
pancreatitis
Headline:
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
Do Not Allow Advertisers to Use My Personal information
